Neuro-Oncology Working Group
Childhood and adolescent central nervous system (CNS) tumors, constituting 25% of new childhood cancer diagnoses, exhibit heterogeneity. Advances in molecular diagnostics, reflected in the 2021 WHO classification, offer additional treatment options. A multidisciplinary team is vital for effective management due to the high mortality and morbidity in this age group, despite improving survival rates.
General Rules
Membership:
All ordinary and extraordinary SSPHO members can participate as a member of a Working Group. Preferably, each Swiss paediatric haematology oncology center should be represented as well as Young Investigators. Also, representatives from related disciplines like surgery, pathology, radiology, radiation oncology, rehabilitation, nursing, and patient representatives should be involved. Importantly, working group members are obliged to actively participate in the group.
Meetings:
Meetings with all working group members will take place approximately every 3 months, either in person or online tool. The Chair and Vice-Chair are responsible for working group meetings. Additional meetings can be scheduled for sub-groups or projects within the working groups, where only selected members are involved.